Filing Details

Accession Number:
0001013762-10-000940
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-23 13:00:00
Reporting Period:
2009-11-13
Filing Date:
2010-04-23
Accepted Time:
2010-04-23 19:24:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1140098 Advanced Cell Technology Inc. OTCBB:ACTC Pharmaceutical Preparations (2834) 870656515
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1317093 Robert Lanza 381 Plantation Street
Worchester MA 01605
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2010-02-04 30,192,203 $0.00 30,192,203 No 4 A Direct
Common Stock, Par Value $0.001 Disposition 2010-04-20 14,023 $0.09 30,178,180 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-20 25,000 $0.09 30,153,180 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-20 400,000 $0.09 29,753,180 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2009-11-13 5,350,000 $0.00 5,350,000 $0.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,350,000 2019-11-13 No 4 A Direct
Footnotes
  1. The shares and options, respectively, were issued pursuant to the Company's 2005 Stock Incentive Plan.
  2. 50% of the options vest immediately and 50% vest over 12 months.